Fortrea Holdings Inc. (FTRE) vs Vir Biotechnology, Inc. (VIR)
Fortrea Holdings Inc. and Vir Biotechnology, Inc. are both Biotechnology companies. Fortrea Holdings Inc. and Vir Biotechnology, Inc. are of similar size ($1.9B and $1.8B). Vir Biotechnology, Inc. grew revenue faster over the last twelve months: 1,495.9% against −2.09%. Fortrea Holdings Inc. has the higher net margin (−3.18% vs −83.0%) and the higher return on invested capital (−0.48% vs −39.1%). Across the 18 metrics below, Fortrea Holdings Inc. leads on 11 and Vir Biotechnology, Inc. on 7.
Valuation
Profitability
| Metric | FTRE | VIR | Biotechnology median |
|---|---|---|---|
| Gross margin | 19.30% | 100.00% | 65.16% |
| Operating margin | (0.40%) | (92.40%) | 0.00% |
| Net margin | (3.18%) | (83.00%) | 0.00% |
| Free cash flow margin | 7.40% | (67.17%) | 0.00% |
| Return on equity | (15.30%) | (26.08%) | (57.72%) |
| Return on assets | (3.07%) | (20.91%) | (49.22%) |
| Return on invested capital | (0.48%) | (39.10%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack